PAP-1
PAP-1 (5- (4-Phenoxybutoxy) psoralen) is a potent, selective, and orally active Kv1.3 blocker (EC50=2 nM) . PAP-1 blocks Kv1.3 in a use-dependent manner and acts by preferentially binding to the C-type inactivated state of the channel. PAP-1 exhibits 23-fold selectivity over Kv1.5 (EC50=45 nM), and further displays 33- to 125-fold selectivity over all other Kv1-family channels. PAP-1 does not exhibit cytotoxic or phototoxic effects[1][2].
Product Specifications
CAS Number
870653-45-5
Product Name Alternative
5- (4-Phenoxybutoxy) psoralen
UNSPSC
12352005
Hazard Statement
H334
Target
Potassium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/PAP-1.html
Purity
99.83
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C=CC(C(O1)=CC2=C3C=CO2)=C3OCCCCOC4=CC=CC=C4
Molecular Formula
C21H18O5
Molecular Weight
350.36
Precautions
H334
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HNF1A (Pancreatic Tumor Suppressor) (HNF1A/2087), CF488A conjugate, 0.1mg/mL
(E/Z)-FK-506 26,28-Allylic Ester Rearrangement Impurity
![Ethyl 4-[[6-(4-Carbamimidoylphenoxy)hexyl]oxy]benzimidoate dihydrochloride](https://cdn.genprice.uk/products/572/6855646103537/imageurl/trc-e901035-50mg.webp)
Ethyl 4-[[6-(4-Carbamimidoylphenoxy)hexyl]oxy]benzimidoate dihydrochloride
HER-2 / c-erbB-2 / neu / CD340 (ERBB2/3080), CF647 conjugate, 0.1mg/mL
